Perceptions and Barriers on the Use of PCSK9 Inhibitors in Heterozygous Familial Hypercholesterolemia

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2020.05.069 ◽

2020 ◽

Vol 14 (4) ◽

pp. 586-587

Author(s):

Matthew Bang ◽

Dean Karalis ◽

Robert Block ◽

Amy Peterson ◽

Nathan Wong

Keyword(s):

Familial Hypercholesterolemia ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Preliminary clinical experience of PCSK9 inhibitors in patients with heterozygous familial hypercholesterolemia. Considerations on their use in patients on lipoprotein apheresis treatment and in statins intolerant patients

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2016.11.012 ◽

2017 ◽

Vol 27 (1) ◽

pp. e4-e5

Author(s):

A. Altomari ◽

V. Sanga ◽

G. Ceradini ◽

A. Fabris ◽

A. Lupo ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Clinical Experience ◽

Pcsk9 Inhibitors ◽

Lipoprotein Apheresis ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors

Atherosclerosis ◽

10.1016/j.atherosclerosis.2016.09.001 ◽

2017 ◽

Vol 256 ◽

pp. 134-145 ◽

Author(s):

Marcello Arca

Keyword(s):

Familial Hypercholesterolemia ◽

Clinical Management ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

The role of PCSK9-inhibitors and of lipoprotein apheresis in the treatment of homozygous and severe heterozygous familial hypercholesterolemia: A rivalry, or are things quite different?

Vnitřní lékařství ◽

10.36290/vnl.2018.007 ◽

2018 ◽

Vol 64 (1) ◽

pp. 43-50

Author(s):

Vladimír Bláha ◽

Milan Bláha ◽

Miriam Lánská ◽

Eduard Havel ◽

Pavel Vyroubal ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Pcsk9 Inhibitors ◽

Lipoprotein Apheresis ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Heterozygous familial hypercholesterolemia with intolerance to PCSK9 inhibitors

Endocrine Abstracts ◽

10.1530/endoabs.73.aep276 ◽

2021 ◽

Author(s):

Miguel Saraiva ◽

Pedro Palma ◽

Alexandre Queirós José ◽

Isabel Palma

Keyword(s):

Familial Hypercholesterolemia ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease

PharmacoEconomics ◽

10.1007/s40273-017-0590-5 ◽

2017 ◽

Vol 36 (1) ◽

pp. 115-126 ◽

Author(s):

Usha G. Mallya ◽

Susan H. Boklage ◽

Andrew Koren ◽

Thomas E. Delea ◽

C. Daniel Mullins

Keyword(s):

Cardiovascular Disease ◽

Familial Hypercholesterolemia ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Adult Patients ◽

Atherosclerotic Cardiovascular Disease ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Rescue therapy with PCSK9 inhibitors for patients with delayed diagnosis of heterozygous familial hypercholesterolemia: Redressing the balance of missed opportunities

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2016.07.003 ◽

2016 ◽

Vol 10 (5) ◽

pp. 1278-1279 ◽

Author(s):

Alpo Vuorio ◽

Gerald F. Watts ◽

Petri T. Kovanen

Keyword(s):

Familial Hypercholesterolemia ◽

Rescue Therapy ◽

Delayed Diagnosis ◽

Pcsk9 Inhibitors ◽

Missed Opportunities ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Differential Responses to the PCSK9 Inhibitors, Evolocumab and Alirocumab, in a Patient with Heterozygous Familial Hypercholesterolemia: A Case Report

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2018.03.064 ◽

2018 ◽

Vol 12 (2) ◽

pp. 558-559

Author(s):

Michael Doyle

Keyword(s):

Case Report ◽

Familial Hypercholesterolemia ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia ◽

Differential Responses

Download Full-text

Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience.

Journal of Clinical Lipidology ◽

10.1016/j.jacl.2021.04.011 ◽

2021 ◽

Author(s):

Rodrigo Alonso ◽

Ovidio Muñiz-Grijalvo ◽

Jose Luis Díaz-Díaz ◽

Daniel Zambón ◽

Raimundo de Andrés ◽

...

Keyword(s):

Clinical Practice ◽

Familial Hypercholesterolemia ◽

Pcsk9 Inhibitors ◽

Heterozygous Familial Hypercholesterolemia ◽

Practice Experience

Download Full-text

Decreased Elasticity of Proximal Ascending Aorta in Heterozygous Familial Hypercholesterolemia: Echocardiographic Analysis

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)83948-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 55A

Author(s):

M Vaturi

Keyword(s):

Familial Hypercholesterolemia ◽

Ascending Aorta ◽

Heterozygous Familial Hypercholesterolemia

Download Full-text

Effect of Quantitative and Qualitative Diet Prescription on Children Behavior after a Diagnosis of Heterozygous Familial Hypercholesterolemia

SSRN Electronic Journal ◽

10.2139/ssrn.3238292 ◽

2018 ◽

Author(s):

Arrigo F.G. Cicero ◽

Federica Fogacci ◽

Marina Giovannini ◽

Marilisa Bove ◽

Giuliana Debellis ◽

...

Keyword(s):

Familial Hypercholesterolemia ◽

Heterozygous Familial Hypercholesterolemia ◽

Children Behavior

Download Full-text